- Home
- SERA vs NTRB Comparison
SERA vs NTRB Comparison
Compare SERA & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- NTRB
- Stock Information
- Founded
- SERA 2008
- NTRB 2016
- Country
- SERA United States
- NTRB United States
- Employees
- SERA N/A
- NTRB N/A
- Industry
- SERA Precision Instruments
- NTRB Industrial Specialties
- Sector
- SERA Health Care
- NTRB Health Care
- Exchange
- SERA Nasdaq
- NTRB Nasdaq
- Market Cap
- SERA 85.6M
- NTRB 82.3M
- IPO Year
- SERA 2021
- NTRB N/A
- Fundamental
- Price
- SERA $2.38
- NTRB $6.44
- Analyst Decision
- SERA
- NTRB Buy
- Analyst Count
- SERA 0
- NTRB 1
- Target Price
- SERA N/A
- NTRB $13.00
- AVG Volume (30 Days)
- SERA 102.6K
- NTRB 192.2K
- Earning Date
- SERA 08-06-2025
- NTRB 09-02-2025
- Dividend Yield
- SERA N/A
- NTRB N/A
- EPS Growth
- SERA N/A
- NTRB N/A
- EPS
- SERA N/A
- NTRB N/A
- Revenue
- SERA $108,000.00
- NTRB $2,398,437.00
- Revenue This Year
- SERA $390.13
- NTRB $560.75
- Revenue Next Year
- SERA $440.54
- NTRB $588.39
- P/E Ratio
- SERA N/A
- NTRB N/A
- Revenue Growth
- SERA 0.94
- NTRB 18.92
- 52 Week Low
- SERA $1.37
- NTRB $2.98
- 52 Week High
- SERA $9.13
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- SERA 46.00
- NTRB 39.08
- Support Level
- SERA $2.17
- NTRB $6.05
- Resistance Level
- SERA $2.50
- NTRB $6.67
- Average True Range (ATR)
- SERA 0.19
- NTRB 0.44
- MACD
- SERA -0.02
- NTRB -0.04
- Stochastic Oscillator
- SERA 33.66
- NTRB 22.54
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.